SPONSOR

Wake Forest University Health Sciences

Total Trials

Recruiting

Phases

Phase 4, Phase 2, Phase 1, Phase 3

Conditions studied: Hypertension Left Ventricular Hypertrophy Left Ventricular Dysfunction Left Atrial Dilatation Left Ventricular Diastolic Dysfunction Kidney Diseases Kidney Injury Kidney Dysfunction Sodium Urine High Blood Pressure Disorders

Wake Forest University Health Sciences is a clinical research sponsor with 27 registered studies on ClinicalTrials.gov, of which 27 are actively recruiting participants. Research covers conditions including Hypertension, Left Ventricular Hypertrophy, Left Ventricular Dysfunction, Left Atrial Dilatation.

The trial portfolio spans Phase 4, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Wake Forest University Health Sciences

How many clinical trials has Wake Forest University Health Sciences sponsored?

ClinicalMetric currently tracks 27 clinical trials sponsored by Wake Forest University Health Sciences, of which 27 are actively recruiting participants. These trials cover conditions including Hypertension, Left Ventricular Hypertrophy, Left Ventricular Dysfunction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Wake Forest University Health Sciences research focus on?

Wake Forest University Health Sciences clinical trials span Hypertension, Left Ventricular Hypertrophy, Left Ventricular Dysfunction, Left Atrial Dilatation, Left Ventricular Diastolic Dysfunction, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Wake Forest University Health Sciences clinical trial?

To participate in a Wake Forest University Health Sciences trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Wake Forest University Health Sciences trials with current recruitment status updated daily.

Wake Forest University Health Sciences

Frequently Asked Questions — Wake Forest University Health Sciences

Clinical Trials by Wake Forest University Health Sciences

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors

RIsE Stroke Mobility Study

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity

Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients

Utility of a Mobile Application for Young Women With Breast Cancer

Comprehensive Care for AYA: Needs Assessment Survey

Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers

Primary Subtalar Arthrodesis for Calcaneal Fractures

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy

Microneedling vs Dermabrasion for Early Facial Scar Resurfacing

Evaluation of a Health System Integrated Model for Postpartum Education and Support in Rural Populations

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography

Vibegron for ENergy Thinking and Resilience in Aging

Optimizing Sustainable Cuff Access and Training Pathways for Self-Measured Blood Pressure Monitoring in Primary Care

Oral Gastric Suctioning Effect on Transesophageal Echo

Physician Engagement in EMS Transport Refusal Rates

Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Evaluation of Flexible Conductive Hearing Aids

LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy and Spectroscopy-based Molecular Urinalysis in Sarcoma Patients